Corcept Therapeutics Balance Sheet (2010-2026) | CORT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	95.43M	94.69M	77.62M	61.86M	35.35M	50.24M	66.33M	299.94M	172.38M	111.80M	135.55M	149.75M	128.59M	137.29M	127.67M	89.82M	102.75M	125.14M	120.50M	108.74M
Short-term Investments (Quarter)	274.55M	266.64M	145.92M	283.67M	334.74M	346.02M	365.34M	165.12M	190.88M	243.43M	232.67M	261.01M	344.57M	243.05M	255.67M	232.94M	239.48M	296.55M	251.66M	229.45M
Cash & Current Investments (Quarter)	369.98M	361.33M	223.53M	345.53M	370.09M	396.26M	431.67M	465.06M	363.26M	355.23M	368.22M	410.76M	473.16M	380.34M	383.33M	322.76M	342.23M	421.68M	372.15M	338.18M
Receivables - Net (Quarter)	27.62M	26.51M	27.62M	27.18M	28.16M	29.41M	31.06M	32.56M	32.55M	34.63M	41.12M	61.52M	53.84M	59.72M	53.98M	61.82M	64.57M	69.63M	59.79M	39.07M
Receivables - Other (Quarter)	1.40M	1.40M		1.00M	1.70M	0.90M	14.00M	14.00M	14.00M	14.00M	14.00M		2.30M	2.90M	4.10M	18.20M	4.10M	3.90M	4.10M
Receivables (Quarter)	29.02M	27.91M	27.62M	28.18M	29.86M	30.31M	45.06M	46.56M	46.55M	48.63M	55.12M	61.52M	56.14M	62.62M	58.08M	80.02M	68.67M	73.53M	63.89M	39.07M
Raw Materials (Quarter)												0.70M
Work In Process (Quarter)	14.38M	13.73M	11.45M	12.64M	11.37M	11.17M	7.83M	8.51M	6.68M	8.74M	8.23M	7.13M	8.45M	7.76M	7.79M	7.04M	11.80M	14.20M	13.70M	11.81M
Finished Goods (Quarter)	5.02M	4.93M	6.50M	5.54M	6.04M	5.90M	9.20M	8.05M	9.00M	7.52M	7.74M	7.20M	8.35M	8.05M	8.21M	8.50M	6.72M	8.60M	9.41M	14.69M
Inventory (Quarter)	4.67M	4.99M	4.99M	5.08M	5.44M	6.05M	6.10M	6.41M	6.92M	7.51M	7.73M	7.19M	8.35M	8.05M	12.41M	14.37M	12.28M	12.35M	12.87M	12.89M
Prepaid Assets (Quarter)	9.00M	9.07M	10.31M	10.44M	15.36M	20.68M	16.42M	15.87M	15.86M	20.16M	27.56M	18.36M	9.13M	4.58M	6.08M	39.55M	7.47M	37.47M	40.66M	6.38M
Current Assets (Quarter)	411.27M	401.90M	266.46M	388.22M	419.05M	452.40M	499.25M	533.89M	432.59M	431.53M	458.64M	503.37M	560.85M	466.98M	471.60M	438.50M	443.11M	541.13M	485.46M	426.03M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.41M	1.23M	1.00M	0.73M	0.86M	0.80M	0.63M	0.46M	0.41M	0.30M	0.20M	0.13M	1.47M	2.93M	2.69M	2.54M	2.35M	2.09M	1.89M	3.17M
Long-Term Investments (Quarter)	101.66M	133.84M	112.28M	22.57M	11.89M	4.89M	4.95M			59.62M	57.18M	40.28M	19.32M	167.31M	219.83M	248.04M	172.78M	102.56M	160.27M	177.26M
Long-Term Deferred Tax (Quarter)	33.74M	29.64M	27.45M	37.71M	48.49M	57.34M	61.47M	68.00M	78.21M	87.10M	90.61M	97.87M	111.85M	126.80M	130.91M	144.44M	162.23M	153.00M	168.20M	181.56M
Other Non-Current Assets (Quarter)	4.14M	4.11M	3.08M	2.98M	1.83M	5.08M	5.06M	4.76M	4.41M	6.54M	6.54M	6.39M	6.94M	6.97M	6.61M	6.61M	8.30M	8.05M	5.15M	5.15M
Non-Current Assets (Quarter)	157.21M	183.50M	157.29M	79.90M	77.32M	80.85M	84.18M	83.95M	92.04M	162.50M	162.88M	152.57M	153.71M	317.28M	368.95M	407.95M	358.61M	282.48M	351.19M	388.85M
Assets (Quarter)	568.48M	585.40M	423.76M	468.12M	496.36M	533.25M	583.43M	617.85M	524.62M	594.02M	621.52M	655.93M	714.55M	784.26M	840.55M	846.46M	801.72M	823.61M	836.65M	814.88M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	9.22M	6.56M	6.91M	9.27M	8.25M	8.18M	11.98M	11.22M	7.98M	16.71M	17.40M	12.56M	19.48M	18.58M	15.38M	27.95M	23.52M	34.45M	40.44M	33.31M
Payables (Quarter)	9.22M	6.56M	6.91M	9.27M	8.25M	8.18M	11.98M	11.22M	7.98M	16.71M	17.40M	12.56M	19.48M	18.58M	15.38M	27.95M	23.52M	34.45M	40.44M	33.31M
Accumulated Expenses (Quarter)	13.11M	12.84M	12.44M	13.05M	24.74M	29.41M	30.80M	13.98M	14.00M	69.63M	51.63M	24.82M		79.46M	90.70M	25.26M	91.07M	108.45M	90.60M	34.09M
Other Accumulated Expenses (Quarter)			12.44M		13.80M		14.57M		18.61M	21.30M	21.33M		21.97M	27.74M	33.87M		29.05M	28.32M	33.95M
Short term Debt (Quarter)
Current Leases (Quarter)	1.56M	1.05M	0.53M	2.26M	2.26M	1.71M	1.14M	0.57M	0.30M	0.23M	0.15M	0.08M	0.04M	0.43M	0.83M	0.98M	1.02M	1.05M	1.08M	1.63M
Current Taxes (Quarter)
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	45.40M	44.76M	47.54M	57.24M	49.06M	53.07M	72.49M	78.86M	93.06M	121.87M	104.50M	97.20M	100.75M	126.22M	140.77M	143.07M	144.66M	172.26M	166.09M	149.19M
Non-Current Liabilities
Non-Current Debt (Quarter)
Operating Leases (Quarter)				2.80M	2.26M	1.71M	1.14M	0.57M	0.30M	0.23M		0.08M	5.67M	6.79M	6.11M	6.83M	5.59M	5.31M	5.02M	9.64M
Other Non-Current Liabilities (Quarter)	0.40M	0.41M	0.41M	2.52M	4.98M	6.82M	9.10M	9.40M	9.95M	10.47M	10.31M	10.87M	11.94M	12.85M	14.08M	14.25M	15.68M	14.13M	15.18M	15.33M
Total Non-Current Liabilities (Quarter)	45.40M	44.76M	47.54M	57.80M	49.06M	53.07M	72.49M	78.86M	93.06M	121.87M	104.50M	97.20M	106.38M	132.57M	146.88M	148.92M	150.25M	177.57M	173.67M	161.56M
Total Liabilities (Quarter)	45.80M	45.17M	47.95M	60.31M	54.04M	59.89M	81.59M	88.26M	103.01M	132.34M	114.81M	108.07M	118.31M	145.42M	160.96M	163.17M	165.93M	191.71M	188.85M	176.89M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	522.67M	540.23M	375.81M	407.81M	442.33M	473.36M	501.84M	529.58M	421.61M	461.68M	506.70M	547.86M	596.24M	638.84M	679.59M	683.28M	635.79M	631.90M	647.80M	637.99M
Shareholder's Equity (Quarter)	522.67M	540.23M	375.81M	407.81M	442.33M	473.36M	501.84M	529.58M	421.61M	461.68M	506.70M	547.86M	596.24M	638.84M	679.59M	683.28M	635.79M	631.90M	647.80M	637.99M
Liabilities and Shareholders Equity (Quarter)	568.48M	585.40M	423.76M	468.12M	496.36M	533.25M	583.43M	617.85M	524.62M	594.02M	621.52M	655.93M	714.55M	784.26M	840.55M	846.46M	801.72M	823.61M	836.65M	814.88M
Treasury Shares (Quarter)	1.36M	1.22M	3.87M	0.20M	0.10M	0.20M	0.46M	23.40M	6.61M	0.10M	6.61M	0.02M	0.12M	0.34M	1.24M	0.50M	1.48M	0.60M	2.60M
Retained Earnings (Quarter)	0.21M	162.91M	-0.23M	217.76M	245.18M	279.79M	296.39M	312.26M	339.79M	-0.23M	0.61M	0.26M	465.78M	512.99M	-0.22M	0.69M	599.43M	619.10M	2.26M	611.63M

Research Tools

Corcept Therapeutics Balance Sheet (2010-2026) | CORT

Create an account

Sign In

Reset Password